How to Invest in CGM Fly Production?

What is CGM Fly System developed by MLC?

CGM Fly is a continuous blood glucose monitoring system developed by MLC Health Engineering. It is a flagship product designed with competitive advantages such as proprietary biosensor technology, a longer sensor lifespan (15 days), artificial intelligence integration, compact and waterproof design, and a stylish appearance.

The product targets emerging markets in the Middle East, Asia, and Africa, where there is a growing demand due to the high prevalence of diabetes. MLC aims not only to compete globally but to penetrate new, developing markets with this premium yet affordable product.

The CGM Fly production is linked to a project by a company named MLC developing continuous glucose monitoring (CGM) systems, branded as CGM Fly. They are preparing to launch the first contract manufacturing line for their CGM Fly system in China with a production capacity of up to 10 million units per year.

The project is an investment opportunity focusing on contract manufacturing without requiring heavy investment in equipment or facilities. The investment proposal highlights potential risks such as technical development delays, regulatory approvals, and market demand variations.

To invest in CGM Fly production, it appears you can participate in the MLC project, which currently allows investments using USDT (a cryptocurrency stablecoin) with a promotional bonus of +20% on the deposit amount available until November 20, 2025.

This investment approach suggests a direct investment or funding method through their platform rather than through public stock or traditional securities. The CGM Fly system's technology is proprietary, aiming at a long sensor life and entry into a market with moderate competition.

In summary:

• CGM Fly production is by MLC, which is launching contract manufacturing in China.
• Investment is open through MLC's platform using USDT with a current promotion.
• The production line aims for high volume (10 million units/year).
• Risks include development, regulatory, and market demand.
• The project is focused on innovative CGM technology in the healthcare sector.

If interested, investing directly through MLC's platform before the closing date (Nov 20, 2025) seems the way to invest in CGM Fly production

Conclusion: Investing in MLC means becoming a co-owner of the CGM Fly Technology and production. Investment opportunities involve participation in funding for the production line and technology development of this innovative health tech device. MLC offers an investment model where shareholders can benefit from early-stage entry into a fast-growing health technology sector, especially in untapped international markets. To invest, one typically registers with MLC's platform or investment channels offering shares related to CGM Fly technology and production.